Ozempic

Is the success of this drug due to a society that is more health-conscious, or just more concerned with aesthetics?

A small-scale study suggests that patient psychology may limit the effectiveness of GLP-1 agonist medications

A nutritionist, a sociologist and a gastronomic consultant help us understand the impact of GLP-1 agonists on the food establishments. Some are starting to offer smaller menus for those whose appetite has shrunk

A retrospective macro-study revealed that the use of GLP-1 agonists is associated with a reduction in the overall risk of cancer among obese or overweight patients

Recently, the provocateur has gone from being a marginal figure of the so-called ‘Dark Enlightenment’ to placing himself at the center of the American ideological war, cast as a kind of oracle to the MAGA universe

The Canadian researcher has just received the Frontiers of Knowledge Award for his work on anti-obesity drugs. However, he remains cautious about their use

As anti-obesity drugs gain traction and thinness is increasingly equated with health, the movement to accept diverse body types is being sidelined

The British drug agency is monitoring a possible increase in cases of the disease, although there is no data yet to warrant alarm

An analysis of thousands of people suggests that these strategies, especially eating every other day, are an alternative to traditional weight loss methods

Novo Nordisk’s campaign, which aims to speak ‘without filters’ by declaring obesity a disease, has been strongly criticized on social media: ‘It’s indecent’

A trial shows that semaglutide stops fat accumulation and liver fibrosis in a disease associated with metabolic dysfunction

New research shows that this method leads to greater weight loss and improved metabolism. Possible rebound effects were not analyzed

The next generation of treatments aims to help patients lose a quarter of their weight

The writer has published ‘Magic Pill,’ a book where based on his own experience with weight-loss drugs he embarks on a journey about the impact of these revolutionary treatments

Novo Nordisk, the largest European company by market capitalization, has achieved worse than expected results for its new slimming drug CagriSema

Many projects, such as quitting smoking or eating healthier, end up being abandoned, but that doesn’t diminish the value of the attempt

The doctor, who holds degrees from Harvard Medical School, is confident in anti-aging treatments such as metformin or PARP1 inhibitors. But until these are approved, he practices intermittent fasting

Research reports that in the United States, the number of patients who underwent bariatric procedure decreased by 25%, while the number of patients prescribed the new drugs increased by 123%

The B-side of the weight-loss medication’s growing popularity is a slimmed-down face that can make a person look older

Australian tycoon Aron D’Souza wants to organize the controversial Enhanced Games, a competition that still has no date or location, which sets out to test the limits of the human body by allowing performance-enhancing drugs

As more pharmaceutical companies make inroads in the weight loss market, the two firms saw their shares fall more than 10% in the last month

The rich and famous may fill his waiting room, but he is the real star. One of the most famous doctors in New York welcomes EL PAÍS to dismantle the myths and legends of skincare

The scientist — ignored in previous award ceremonies — has won the Princess of Asturias Award for Technical and Scientific Research, for her role in the revolution of medications being used to treat obesity and diabetes

Now we have medications for obesity, but they are not for losing a couple of kilos. An integrative approach of all available measures is needed

Researchers have used artificial intelligence to find out why some people have a better response to GLP-1 agonists

Around the world, 100 companies have debuted weight-loss medications, which have become a multimillion-dollar business. Novo Nordisk’s Ozempic is currently the best-known, but it’s far from the only option